SCIDEV LIMITED (SDV)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SDV - SCIDEV LIMITED

Year End: June
GICS Industry Group : NONE
Debt/EBITDA: 0.58
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.505

20 Nov
2024

0.050

OPEN

$0.47

10.99%

HIGH

$0.51

381,814

LOW

$0.47

OTHER COMPANIES IN THE SAME SECTOR
3DA . ALQ . AVD . BSA . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGN . EVS . FLC . IPG . LBL . MAD . PPK . RWL . SHA . SND . SSM . VEE . VNT .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx1.2
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx109.1 M
Book Value Per Share xxxxxxxxxxxxxxx26.5
Net Operating Cash Flow xxxxxxxxxxxxxxx6.5 M
Net Profit Margin xxxxxxxxxxxxxxx1.99 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx4.43 %
Return on Invested Capital xxxxxxxxxxxxxxx4.25 %
Return on Assets xxxxxxxxxxxxxxx3.12 %
Return on Equity xxxxxxxxxxxxxxx4.43 %
Return on Total Capital xxxxxxxxxxxxxxx8.80 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx4.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxxxxx5 M
Goodwill - Gross xxxxxxxxxxxxxxx21 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx9 M
Price To Book Value xxxxxxxxxxxxxxx1.40

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx2.1 M
Capex % of Sales xxxxxxxxxxxxxxx1.89 %
Cost of Goods Sold xxxxxxxxxxxxxxx98 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx7 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

01/11/2024

1

Buy

$0.74

46.53%

Canaccord Genuity reiterates a Buy rating on SciDev, lifting the target price to 74c from 68c, despite a slight revenue dip due to project timing in Q1.

Quarterly gross margins strengthened to 29% from around 26% in 4Q24, while earnings (EBITDA) increased by 29% quarter-on-quarter, indicating operational resilience.

The broker expects tailwinds from upcoming per-and polyfluoroalkyl substances (PFAS) contracts, with potential margin expansion from a steady project pipeline. 

FORECAST
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.90 cents.
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 4.00 cents.

SDV STOCK CHART